0001079973-16-001182.txt : 20160915 0001079973-16-001182.hdr.sgml : 20160915 20160915155449 ACCESSION NUMBER: 0001079973-16-001182 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160915 DATE AS OF CHANGE: 20160915 EFFECTIVENESS DATE: 20160915 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Venaxis, Inc. CENTRAL INDEX KEY: 0001167419 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 841553387 STATE OF INCORPORATION: CO FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-270761 FILM NUMBER: 161887198 BUSINESS ADDRESS: STREET 1: 1585 S. PERRY STREET CITY: CASTLE ROCK STATE: CO ZIP: 80104 BUSINESS PHONE: (303) 794-2000 MAIL ADDRESS: STREET 1: 1585 S. PERRY STREET CITY: CASTLE ROCK STATE: CO ZIP: 80104 FORMER COMPANY: FORMER CONFORMED NAME: AspenBio Pharma, Inc. DATE OF NAME CHANGE: 20051110 FORMER COMPANY: FORMER CONFORMED NAME: ASPENBIO INC DATE OF NAME CHANGE: 20020213 D 1 primary_doc.xml X0707 D LIVE 0001167419 Venaxis, Inc. 1585 S. PERRY STREET CASTLE ROCK CO COLORADO 80104 (303) 794-2000 COLORADO AspenBio Pharma, Inc. ASPENBIO INC Corporation true Stephen T. Lundy c/o Venaxis, Inc. 1585 S. PERRY ST CASTLE ROCK CO COLORADO 80104 Executive Officer Director Gail S. Schoettler c/o Venaxis, Inc. 1585 S. PERRY ST CASTLE ROCK CO COLORADO 80104 Director Susan A. Evans c/o Venaxis, Inc. 1585 S. PERRY ST CASTLE ROCK CO COLORADO 80104 Director Daryl J. Faulkner c/o Venaxis, Inc. 1585 S. PERRY ST CASTLE ROCK CO COLORADO 80104 Director David E. Welch c/o Venaxis, Inc. 1585 S. PERRY ST CASTLE ROCK CO COLORADO 80104 Director Stephen A. Williams c/o Venaxis, Inc. 1585 S. PERRY ST CASTLE ROCK CO COLORADO 80104 Director Jeffrey G. McGonegal c/o Venaxis, Inc. 1585 S. PERRY ST CASTLE ROCK CO COLORADO 80104 Executive Officer Other Health Care Decline to Disclose 06b false 2016-09-12 false true true Pursuant to an acquisition transaction that occurred on 09/12/2016, the Issuer issued 627,010 shares of common stock. 0 1950000 1950000 0 The offering amount represents the market value of shares issued as acquisition consideration as of a certain date. See Item 10. false 17 0 0 0 The shares were issued as consideration in an acquisition transaction. See Item 10. false Venaxis, Inc. /s/ Jeffrey G. McGonegal Jeffrey G. McGonegal Chief Financial Officer and Secretary 2016-09-15